DN

David Nierengarten Wedbush Latest Price Targets & Analyst Ratings

Main Sector
Healthcare
Ratings Past Year
52
Avg Return
Past Year
17%
Success Rate
Past Year
0 %
Rating Distribution Past Year
Positive 82%
Neutral 16%
Negative 2%
Stock Rating Price Target Upside
Downside
Ratings
1 Year
Avg Return
1 Year
Success Rate
1 Year
Date
Neutral Downgraded
$129
0%
downside
2 +24%
0 %
2 Jun ‘25 10 months ago
Neutral Downgraded
$12
18%
upside
1
28 May ‘25 10 months ago